Growth Hormone and Heart Failure
Heart failure induces modification in several neurohormonal systems. The aim of this study is to determine if the growth hormone/IGF1 axis is modified in heart failure patients compared to healthy volunteers.
Heart Failure, Congestive
|Study Design:||Observational Model: Case Control
Time Perspective: Cross-Sectional
|Official Title:||Modifications of the Growth Hormone/IGF1 Axis in Heart Failure Patients|
|Study Start Date:||September 2000|
|Estimated Study Completion Date:||February 2003|
One hundred and sixty three heart failure patients were evaluated by clinical examination, echocardiography, exercise test and measurement of blood BNP. Growth hormone and IGF-1 plasma levels were determined in each patient. The same biological measurements were performed in a group of 148 healthy controls. Comparisons were performed between groups for Growth hormone plasma level, IGF-1 plasma level and Growth hormone/IGF-1 index. A correlation between the severity of heart failure and the different biological parameters was searched.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00190359
|Principal Investigator:||Patrick Maison, MD, PhD||APHP|